Latest European Market News

European Lithium has sold 0.5 million shares of Critical Metals Corp for US$1.625 million, underscoring the substantial value of its remaining CRML stake, now valued at approximately US$205 million.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Sprintex secures a key deposit from Mest Water to develop new compressors for mobile manure processing systems, leveraging a Dutch government subsidy aimed at thousands of small farms.

Unibail-Rodamco-Westfield will voluntarily delist from the ASX by late August 2025, citing low liquidity and rising compliance costs. Australian investors holding CHESS Depositary Interests face key decisions on how to manage their holdings.

Collins Foods reported a record $1.52 billion revenue for FY25 with flat EBITDA despite tough market conditions, while signaling optimism for low to mid-teens NPAT growth in FY26.

Bioxyne Limited has upgraded its FY2025 revenue guidance to approximately $28 million, driven by strong domestic performance and significant progress in European and UK markets. The company also advances its psychedelic medicines pipeline, positioning itself for sustained growth.

Critical Metals Corp has landed a conditional US$120 million funding letter from the US Export-Import Bank to advance its Tanbreez rare earth project in Greenland, a move that could reshape Western critical minerals supply chains.

Osmond Resources has confirmed extensive mineralised outcrops spanning 12 kilometres at its Orion EU Critical Minerals Project in southern Spain, while expanding metallurgical test work to include silicon metal, a key EU strategic raw material.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Cash Converters has secured a £12 million growth facility from Lloyds Bank and agreed to acquire 10 UK franchise stores, marking a significant step in its UK expansion strategy.

ADX Energy has formalised licence amendments and identified four drill-ready shallow gas prospects in Upper Austria, targeting Q4 2025 for initial drilling. The company is advancing farm-in discussions to capitalise on a low-risk, pipeline-proximate gas opportunity in a sought-after European market.